Azitra (NYSEAMERICAN:AZTR) Shares Set to Reverse Split on Friday, August 22nd

Shares of Azitra, Inc. (NYSEAMERICAN:AZTR) are set to reverse split on the morning of Friday, August 22nd. The 100-666 reverse split was announced on Monday, August 11th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, August 21st.

Azitra Stock Performance

NYSEAMERICAN:AZTR opened at $0.15 on Thursday. Azitra has a 52 week low of $0.14 and a 52 week high of $0.80. The stock’s 50-day moving average price is $0.23 and its 200-day moving average price is $0.29.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Azitra stock. National Bank of Canada FI boosted its position in shares of Azitra, Inc. (NYSEAMERICAN:AZTR) by 175.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,000 shares of the company’s stock after purchasing an additional 70,000 shares during the period. National Bank of Canada FI owned approximately 0.88% of Azitra worth $34,000 at the end of the most recent quarter. 11.16% of the stock is owned by institutional investors.

Azitra Company Profile

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.